Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Posts Tagged ‘fox’

« Older Entries

Seeking A Less Toxic Radiation Treatment For HPV-Positive Oropharynx Cancer

By on Monday, June 3rd, 2013 | No Comments

Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT)…

Read More...

New Prostate Cancer Tests

By on Thursday, April 18th, 2013 | No Comments

Dr David Samadi joins the Fox News team to discuss the development of a new prostate cancer test that offers more accurate results than the current standard …

Read More...

Tool Could Help Discover New Compounds, Combinations; Quickly Identify Most Effective Gastrointestinal Stromal Tumor Treatments

By on Thursday, April 11th, 2013 | No Comments

A new preclinical technology enables researchers to quickly determine if a particular treatment is effective against gastrointestinal stromal tumors (GISTs), providing a boost to animal research and possibly patient care, according to new findings presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013…

Read More...

A New Way Found To Boost Common Cancer Drugs

By on Wednesday, January 16th, 2013 | No Comments

Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue of Cancer Discovery…

Read More...

The $93000 Cancer Treatment

By on Thursday, January 3rd, 2013 | No Comments

Dr. Bernard Chinnasami of Emerywood Hematology/Oncology in High Point discusses Provenge, the $93000 Cancer Treatment, on this clip from Fox 8 News.

Read More...

Fox Chase study finds new small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer

By on Tuesday, December 11th, 2012 | No Comments

Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer’s biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor. Mesupron is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a recent phase II clinical study from the Fox Chase Cancer Center suggest that the drug could be a safe and first-line treatment that extends progression-free survival for metastatic breast cancer patients, when combined with the chemotherapeutic drug Capecitabine.

Read More...

Findings Suggest Doctors Could One Day Block Protein Tied To Cancer-Drug Resistance And Boost The Ability Of Drugs To Kill Tumors

By on Tuesday, December 11th, 2012 | No Comments

Blocking a specific protein renders tumors more vulnerable to treatment in mice, suggesting new therapies could eventually achieve the same in humans, according to new research from Fox Chase Cancer Center, presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium…

Read More...

Fox Chase study finds attitudes predict ability to follow post-treatment advice

By on Sunday, December 9th, 2012 | No Comments

Women are more likely to follow experts’ advice on how to reduce their risk of an important side effect of breast cancer surgery—like lymphedema—if they feel confident in their abilities and know how to manage stress, according to new research from Fox Chase Cancer Center to be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium on Saturday, December 8, 2012.

Read More...

Fox Chase researchers find that most Medicare patients wait weeks before breast cancer surgery

By on Sunday, November 25th, 2012 | No Comments

Although patients may feel anxious waiting weeks from the time of their first doctor visit to evaluate their breast until they have breast cancer surgery, new findings from Fox Chase Cancer Center show that these waits are typical in the United States. Results were published on Monday, November 19 in the Journal of Clinical Oncology.

Read More...

Fox Chase Researchers Find Routine Blood Test Predicts Prognosis in Aggressive Skin Cancer

By on Friday, November 2nd, 2012 | No Comments

A routine blood test may help predict survival in patients with an aggressive form of skin cancer known as Merkel cell carcinoma, according to new findings by Fox Chase Cancer Center researchers.

Read More...
« Older Entries